全球肢体解剖分期系统与慢性肢体威胁性缺血患者股浅动脉粥样硬化病变内膜下血管成形术中期结局的关系
前瞻性观察研究纳入138例因股浅动脉慢性完全闭塞行内膜下血管成形术的慢性肢体威胁性缺血患者,评估全球肢体解剖分期系统(GLASS)与中期肢体通畅及生存结局的关系。GLASS III与GLASS I相比,一期通畅率显著更差(p=0.005),GLASS I的总生存(p=0.037)、保肢(p=0.021)和无截肢生存(p<0.001)更优。作者认为GLASS分期可能是该术式中期结局的有用预测因素。
要点
- 138例股浅动脉慢性完全闭塞的慢性肢体威胁性缺血患者行内膜下血管成形术,技术成功116例(84%)。
- 1、6、12个月一期通畅率分别为100%、84%、79%,6和12个月保肢率分别为100%和94%。
- GLASS III与GLASS I相比一期通畅率显著更差(p=0.005),GLASS I的总生存(p=0.037)、保肢(p=0.021)和无截肢生存(p<0.001)更优。
核心结论
- 内膜下血管成形术是治疗长段股浅动脉病变安全、有效且微创的选择,可避免患者麻醉和手术风险。
- 本研究提示GLASS分期可能是该术式中期肢体和生存相关结局的有用预测因素。
- 与GLASS I相比,GLASS III解剖与统计学显著更差的一期通畅率、保肢率、无截肢生存和总生存相关。
- GLASS III是一期通畅丧失、无截肢生存更差和重大截肢的独立预测因素。
研究设计与样本
- 前瞻性观察研究,纳入2020年8月至2021年9月所有因股浅动脉慢性完全闭塞行内膜下血管成形术(±同侧血流动力学显著流入/流出病变治疗)的慢性肢体威胁性缺血患者(Rutherford 4-6或WIFI 2-4期)。
- 排除非动脉粥样硬化性股浅动脉闭塞和需要初次重大截肢的患者。
- 共纳入138例患者。
- 采用多变量Cox比例风险回归评估中期临床结局的可能预测因素,Kaplan-Meier生存曲线估计一期通畅、保肢、无截肢生存和总生存。
主要发现
- 初次技术成功116例(84%)。
- 1、6、12个月一期通畅率分别为100%、84%、79%。
- 6和12个月保肢率分别为100%和94%。
- GLASS III与GLASS I比较,一期通畅率显著更差(p=0.005)。
- GLASS I的总生存(p=0.037)、保肢(p=0.021)和无截肢生存(p<0.001)更优。
临床怎么用
- 作者认为内膜下血管成形术是治疗长段股浅动脉病变安全、有效且微创的选择,可避免患者麻醉和手术风险。
- 作者认为GLASS分期可能是该术式中期肢体和生存相关结局的有用预测因素。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Superficial femoral artery (SFA) is commonly affected with atherosclerotic peripheral arterial disease leading to chronic limb-threatening ischemia (CLTI). Subinitimal angioplasty (SIA) is a minimally invasive option. We aimed to examine the relationship between the Global Limb Anatomic Staging System and SIA midterm limb and survival-related outcomes. METHOD: A prospective observational study was conducted on all patients with CLTI (Rutherford 4-6 or WIFI stages 2-4), with diseased femoropopliteal segment underwent SIA from August 2020 to September 2021. Patients with non-atherosclerotic SFA occlusion and those requiring primary major amputation were excluded. Multivariable Cox proportional hazard regression was performed to assess possible predictors of midterm clinical outcomes. Kaplan-Meier survival curves were used to estimate limb-based patency (LBP), limb salvage, amputation-free survival (AFS), and overall survival. RESULTS: The study included 138 patients with CLTI due to chronic total occlusion of the SFA and underwent SIA ± treatment of associated ipsilateral hemodynamically significant inflow/outflow disease. Primary technical success was achieved in 116 cases (84%), with primary patency at 1, 6, and 12 months being 100%, 84%, and 79% respectively, while the limb-salvage rate at 6 and 12 months was 100% and 94%, respectively. The result of the comparison between CLASS 1 and Global Limb Anatomic Staging System III (GLASS III) revealed significantly worse patency with GLASS III (p=0.005), and better overall survival (p=0.037), limb salvage (p=0.021), and AFS (p<0.001) with GLASS I. CONCLUSION: Subinitimal angioplasty is a safe, effective, and minimally invasive treatment option for lengthy SFA lesions by avoiding the patients' anesthesia and operative risk. Our study suggests that the GLASS stage may be a useful predictor of midterm limb and survival-related outcomes of this approach. GLASS III anatomy in comparison with GLASS I is associated with a statistically significantly worse LBP, limb salvage, AFS, and overall survival.Clinical ImpactThis study is discussing a very hot interesting challenging topic in vascular surgery and its management as SFA atherosclerotic lesion is the most common lesion faced by vascular surgeons subintimal angioplasty SIA is considered feasible and effective method in dealing with this lesion with accepted durability and lower rates of complications.The subintimal angioplasty is made by opening an extraluminal track behind the intimal layer and between the media and intima of the artery surrounding atherosclerotic plaque and thrombus. Hence, the track has a low thrombus or plaque burden content, making the SIA easier than intraluminal angioplasty and with comparable results. GLASS stage III was an independent predictor of loss of LBP, worse AFS, and major amputation.
引用
- Shahat M, Atalla K, Abdelmonem M, et al. The Relationship Between the Global Limb Anatomic Staging System and Midterm Outcomes of Subintimal Angioplasty of Superficial Femoral Artery Atherosclerotic Disease in Chronic Limb Threatening Ischemia. J Endovasc Ther. 2023. PMID: 37753707. doi:10.1177/15266028231200466
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。